SMOC1 and pancreatic ductal adenocarcinoma: OAS proteins regulate the tumor microenvironment by modulating immune responses, and the dysregulation of OAS gene expression in pancreatic ductal adenocarcinoma (PDAC) is associated with immune evasion and may affect the efficacy of immunotherapies and the overall prognosis of patients [29, 30].